Objectives-To evaluate the role of a treadmill stress test for identifying patients at risk of recurrent ischaemic events after acute myocardial infarction treated by thrombolysis. Background-The natural history of myocardial infarction has changed with the introduction of thrombolytic treatment; there is a lower mortality but a higher incidence of recurrent thrombotic events (reinfarction, unstable angina). The treadmill stress continues to be recommended for risk stratification after acute myocardial infarction even though its value has never been formally reassessed in the thrombolytic era. Methods-Prospective observational study in which 256 consecutive patients who presented with acute myocardial infarction treated by thrombolysis underwent an early treadmill stress test and were followed up for 10 (range 6-12) months. 
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Objectives-To evaluate the role of a treadmill stress test for identifying patients at risk of recurrent ischaemic events after acute myocardial infarction treated by thrombolysis. Background-The natural history of myocardial infarction has changed with the introduction of thrombolytic treatment; there is a lower mortality but a higher incidence of recurrent thrombotic events (reinfarction, unstable angina). The treadmill stress continues to be recommended for risk stratification after acute myocardial infarction even though its value has never been formally reassessed in the thrombolytic era. Methods-Prospective observational study in which 256 consecutive patients who presented with acute myocardial infarction treated by thrombolysis underwent an early treadmill stress test and were followed up for 10 (range 6-12) months. Results-Recurrent ischaemic events occurred in 41 patients (unstable angina 15, reinfarction 21, death five) and a further 21 required revascularisation. Both ST depression at a low workload and low exercise tolerance (<7 metabolic equivalents of the task (METS) were predictive of recurrent events, with respective hazard ratios of 1-93 (95% confidence interval (95%CI) 1-17-3*20; p < 0.01)) and 1-67 (95% CI 1-0-2*78; p < 0.05). These variables identified 50% and 70% of patients who subsequently sustained a recurrent ischaemic event, but the corresponding values for positive predictive accuracy were only 26% and 21%. Thus Thrombolytic treatment has favourably influenced the natural history of myocardial infarction by reducing mortality in hospital and during early follow up.'-3 Despite reductions in mortality, however, the incidence of recurrent thrombotic events (reinfarction, unstable angina) has increased, and there is now an important need for non-invasive tests to identify those patients at greatest risk.3' The treadmill stress test continues to be recommended for this purpose even though its value has never been formally reassessed in the thrombolytic era.7 The reassessment of the treadmill stress test is necessary because the determinants of recurrent ischaemic events after myocardial infarction have changed with the introduction of thrombolytic treatment. Previously, risk was largely related to left ventricular dysfunction and a propensity to ventricular arrhythmias, as well as to remote ischaemia in patients with multivessel disease. Now, however, many of the recurrent events that occur early after myocardial infarction are the result of coronary re-occlusion in patients who have previously been treated successfully by thrombolysis.8 9 It cannot be assumed, therefore, that the treadmill stress test remains a valid means of identifying high risk patients in the thrombolytic era.'0 In our study we Blockers were prescribed in 84 patients according to the policy of the physician in charge of the individual patient, and were not withdrawn before the stress test.
FOLLOW UP All patients were followed up either by telephone interview or formal review in a clinic, and details of hospital readmissions were then obtained from review of the case notes. The end points recorded were: cardiac death, myocardial infarction, unstable angina, coronary artery bypass surgery, and coronary angioplasty. The diagnostic criteria for reinfarction were the same as for entry into the study. Unstable angina was defined as prolonged cardiac chest pain associated with acute electrocardiogram changes but without a significant rise in cardiac enzymes, that required urgent admission to the coronary care unit. For analytical purposes ischaemic events occurring after revascularisation were not included. (21) , and sudden death (5) . A further nine patients underwent coronary artery bypass surgery either because of 
LIMITATIONS OF THE STUDY
The interpretation of studies of this kind is inevitably confounded by the proportion of patients who undergo revascularisation. As revascularisation is an elective procedure rather than a potentially preventable ischaemic event it may or may not be appropriate to include it as an end point in event free survival analysis. Thus, whereas there is no clinical necessity to identify patients who may require revascularisation in the future, its exclusion as an end point effectively excludes from the analysis those patients who may have been at high risk if treated conservatively. In our study, however, the relation between a stress test and outcome was evaluated with and without revascularisation included as an end point, and there was no major difference between the two analyses. Importantly, patients were not selected for coronary arteriography, and hence potentially for revascularisation, on the basis of findings from the stress test, and therefore outcome was not directly influenced by the result of the stress test itself.
The second potential limitation relates to the choice of end points. In our study, a number of clinical end points have been combined for the purposes of statistical analysis. Although this is common practice in observational studies of this kind, ideally end points should only be combined if they reflect similar underlying pathological mechanisms. Sudden death was included as an ischaemic event despite the possibility that some of these deaths may have been primarily arrhythmic in aetiology. The number of sudden deaths were, however, low compared with the total number of events, and therefore a separate analysis of the relation between a stress test and sudden death would not have been meaningful.
Finally, fi blockers were prescribed in 33% of patients and were not withdrawn before the stress test. Arguably this may have influenced the results of the study, although there is little information available regarding the effects of fi blockers on the diagnostic value of a post-infarction stress test. Certainly ,6 blockers have not always been withdrawn before a stress in previous studies, including those in which the results of the test were strongly predictive of outcome.2432
In conclusion, patients with acute myocardial infarction treated by thrombolysis have a high incidence of recurrent ischaemic events after discharge from hospital. The modest diagnostic capabilities of an early treadmill stress test for identifying accurately this high risk group emphasises the limitations of this technique for selecting patients in need of further investigation and revascularisation. Although selected stress test variables such as ST depression at a low workload and impaired exercise capacity may be of some value for risk stratification, there remains an important need to evaluate other non-invasive methods for this purpose.
